Vitrolife AB ADR | |
Stock Exchange | Other OTC |
EPS |
$0.27 |
Market Cap |
$2.2 B |
Shares Outstanding |
108.55 M |
Public Float |
- |
Vitrolife AB | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK2.98 |
Market Cap |
SEK19.55 B |
Shares Outstanding |
108.55 M |
Public Float |
57.06 M |
Address |
Gustaf Werners Gata 2 Gothenburg VG 421 32 Sweden |
Employees | - |
Website | http://www.vitrolife.com |
Updated | 07/08/2019 |
Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. It operates through the following geographical segments: EMEA, North and South America, and Asia & Pacific. Its products include FertiRoof, Vitrification, Slow freezing, OVOIL-culture oil, and Follicle aspiration needles. |